Viatris (VTRS) to Report Q4 Earnings: What’s in the Cards? Posted byZacks Equity Research February 22, 2022 Leave a comment on Viatris (VTRS) to Report Q4 Earnings: What’s in the Cards? Viatris’ (VTRS) Q4 earnings might have gained from the solid performance of Lipitor, Influvac, Viagra and EpiPen.